OS
Okey Stephanie
Director
OFFICERF
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Okey Stephanie, Director. Officer active across 3 companies, notably Crinetics Pharmaceuticals, Inc.. Aggregated, 25 reports have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €867k. Activity tracked since 13 August 2021. The latest transaction was disclosed on 1 September 2026 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Okey Stephanie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报25 总计
6,400 股@ US$85.000.0060% mcap36.0% 占其流量Common StockSEC:0001628280-26-059905:0
5,925 股@ US$85.000.0056% mcap33.4% 占其流量Common StockSEC:0001628280-26-059905:1
5,925 股Common StockSEC:0001628280-26-044708:0
6,292 股Common StockSEC:0001628280-26-044419:0
608 股Common StockSEC:0001628280-26-044419:1
1,167 股@ US$33.634.2% 占其流量Common StockSEC:0001742616-26-000006:0
6,333 股@ US$63.3843.2% 占其流量Common StockSEC:0001742616-26-000004:0
3,000 股@ US$39.670.0013% mcap50.0% 占其流量Common StockSEC:0001628280-26-014775:0
4,000 股0Common StockSEC:0001742616-26-000002:0
867 股0Common StockSEC:0001742616-25-000006:0
6,900 股0Common StockSEC:0000950170-25-086267:0
5,000 股@ US$54.0052.0% 占其流量Common StockSEC:0001415889-25-008235:0
4,000 股0Common StockSEC:0001415889-25-001024:0
12,635 股Common StockSEC:0000950170-24-137726:0
4,663 股0Common StockSEC:0001596783-24-000109:0
3,400 股0Common StockSEC:0000950170-24-071928:0
17,500 股@ US$18.2959.3% 占其流量Common StockSEC:0001209191-24-005184:0
4,000 股0Common StockSEC:0001415889-24-004116:0
6,993 股0Common StockSEC:0001596783-23-000139:0
979 股0Common StockSEC:0001596783-23-000123:0
6,000 股0Common StockSEC:0001209191-23-038822:0
4,000 股0Common StockSEC:0001415889-23-000667:0
2,296 股@ US$51.62124.4% 占其流量Common StockSEC:0001415889-22-008493:0
3,200 股0Common StockSEC:0001179110-22-000388:0
1,650 股@ US$40.0577.0% 占其流量Common StockSEC:0001179110-21-008233:0
About Okey Stephanie
Okey Stephanie is Director at PTC Therapeutics, INC., Crinetics Pharmaceuticals, Inc. and Catalent, Inc. There are 23 filings in total. In the recent filings sampled, the period runs from 2021-08-17 to 2026-06-22, with EUR 867145 of sales, no purchases, and a modal transaction nature of Attribution.